| Vibostolimab | MK-7684 | Phase 3 Clinical | Merck Sharp & Dohme Corp | Carcinoma, Non-Small-Cell Lung; Melanoma; Neoplasm Metastasis; Solid tumours | Details |
| Domvanalimab | GS-0154; AB-154 | Phase 3 Clinical | Abmuno Therapeutics LLC | Adenocarcinoma; Biliary Tract Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cholangiocarcinoma; Esophageal adenocarcinoma; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Gastrointestinal Neoplasms; Glioblastoma; Liver Neoplasms; Lung Neoplasms; Melanoma; Microsatellite instability-high cancer; Mismatch Repair Deficient Cancer; Pancreatic Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms | Details |
| Tiragolumab | MTIG-7192A; RO-7092284; RG6058-11; RG6058-10; RG-6058 | Phase 3 Clinical | Genentech Inc | Carcinoma; Carcinoma, Hepatocellular; Carcinoma, Medullary; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Chordoma; Colorectal Neoplasms; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Gastroesophageal Junction Neoplasms; Glioblastoma; Head and Neck Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma, B-Cell; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; Melanoma; Metastatic breast cancer; Microsatellite instability-high cancer; Multiple Myeloma; Neoplasm Metastasis; Neoplasms; Oral Squamous Cell Carcinoma; Rectal Neoplasms; Rhabdoid Tumor; Sarcoma; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Teratoma; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms | Details |
| Pembrolizumab/Vibostolimab | MK-7684A | Phase 3 Clinical | Merck & Co Inc | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Endometrial Neoplasms; Esophageal Neoplasms; Gallbladder Neoplasms; Hematologic Neoplasms; Lung Neoplasms; Melanoma; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms | Details |
| SHS-006(Nanjing Sanhome Pharmaceutical) | SHS-006; SH-006; SH006 | Phase 3 Clinical | Nanjing Sanhome Pharmaceutical Co Ltd | Carcinoma, Hepatocellular; Liver Neoplasms; Solid tumours | Details |
| Rilvegostomig | AZD-2936 | Phase 3 Clinical | Astrazeneca Plc | Adenocarcinoma of Lung; Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Merkel Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Cholangiocarcinoma; Cystadenocarcinoma, Serous; Endometrial Neoplasms; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Melanoma; Ovarian Neoplasms; Solid tumours; Squamous Cell Carcinoma of Head and Neck; Stomach Neoplasms; Triple Negative Breast Neoplasms | Details |
| Belrestotug | EOS-884448; GSK-4428859; GSK-4428859A; EOS-448 | Phase 3 Clinical | Iteos | Carcinoma, Non-Small-Cell Lung; Head and Neck Neoplasms; Lung Neoplasms; Melanoma; Multiple Myeloma; Neoplasms; Solid tumours | Details |
| HL-301 | HL-301 | Phase 3 Clinical | Hanmi Pharmaceutical Co Ltd | Acute Bronchitis; Lung Neoplasms; Pulmonary Disease, Chronic Obstructive; Radiation Pneumonitis | Details |
| Ociperlimab | WCD-118; BGB-A1217 | Phase 3 Clinical | BeOne Medicines Ltd | Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Cholangiocarcinoma; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Uterine Cervical Neoplasms | Details |
| Etigilimab | OMP-313M32 | Phase 2 Clinical | Oncomed Pharmaceuticals Inc | Adenocarcinoma, Clear Cell; Fallopian Tube Neoplasms; Neoplasm Metastasis; Neoplasms; Ovarian Neoplasms; Peritoneal Neoplasms; Solid tumours | Details |
| Renvistobart | BMS-986207; ONO-4686 | Phase 2 Clinical | Bristol-Myers Squibb Company | Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Head and Neck Neoplasms; Ovarian Neoplasms; Solid tumours | Details |
| Nilvanstomig | ZG-005 | Phase 2 Clinical | Gensun Biopharma Inc | Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Carcinoma, Neuroendocrine; Carcinoma, Non-Small-Cell Lung; Gastrointestinal Neoplasms; Lymphoma; Nasopharyngeal Carcinoma; Small Cell Lung Carcinoma; Solid tumours; Uterine Cervical Neoplasms | Details |
| AK-130 | AK-130 | Phase 2 Clinical | | Bile Duct Neoplasms; Biliary Tract Neoplasms; Carcinoma, Hepatocellular; Neoplasms; Pancreatic Neoplasms; Solid tumours | Details |
| HB-0036 | HB-0036 | Phase 2 Clinical | HuaBo Biopharm Co Ltd | Carcinoma, Non-Small-Cell Lung; Solid tumours | Details |
| HY-07121 | HY-07121; HY07121 | Phase 2 Clinical | Sichuan Huiyu Seacross Pharma Technology Ltd | | Details |
| PM-1022 | PM-1022 | Phase 2 Clinical | | | Details |
| Lancastotug | AK-127 | Phase 2 Clinical | | Carcinoma, Hepatocellular; Neoplasms; Solid tumours | Details |
| HLX-301 | HLX-301 | Phase 2 Clinical | | Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Lymphoma; Neoplasm Metastasis; Neoplasms; Small Cell Lung Carcinoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck | Details |
| HLX-53 | HLX-53; HLX53 | Phase 2 Clinical | | Carcinoma, Hepatocellular; Lymphoma; Solid tumours | Details |
| PM-1009 | PM1009 | Phase 2 Clinical | | Carcinoma, Hepatocellular; Liver Neoplasms; Lung Neoplasms; Neoplasms; Solid tumours | Details |
| Dargistotug | M-6223; M6223 | Phase 2 Clinical | Emd Serono Research & Development Institute Inc | Carcinoma, Transitional Cell; Solid tumours | Details |
| DW-2008 | DW-2008; DW-2008S | Phase 1 Clinical | Dong Wha Pharm Co Ltd | Asthma; Coronavirus Disease 2019 (COVID-19); Rhinitis, Allergic | Details |
| Tamgiblimab | IBI-939 | Phase 1 Clinical | | Lung Neoplasms; Neoplasms | Details |
| COM-902 | COM-902; CGEN-15137 | Phase 1 Clinical | Compugen Ltd | Colonic Neoplasms; Colorectal Neoplasms; Lung Neoplasms; Multiple Myeloma; Neoplasms; Neoplasms, Plasma Cell; Ovarian Neoplasms; Squamous Cell Carcinoma of Head and Neck | Details |
| HY-0007 | HY-0007 | Phase 1 Clinical | Sichuan Huiyu Pharmaceutical Co Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Lung Neoplasms; Melanoma; Ovarian Neoplasms; Small Cell Lung Carcinoma; Solid tumours | Details |
| SIM-0348 | SIM-0348 | Phase 1 Clinical | Simcere Pharmaceutical Group Ltd | | Details |
| Recombinant humanized anti-TIGIT monoclonal antibody(Lepu biopharma) | LP-010 | Phase 1 Clinical | Lepu Biopharma Co Ltd | | Details |
| ASP-8374 | ASP-8374; PTZ-201 | Phase 1 Clinical | Astellas Pharma Inc, Potenza Therapeutics | Glioblastoma; Solid tumours | Details |
| BMS-986442 | AGEN-1777; BMS-986442; BMS-986-442 | Phase 1 Clinical | Agenus Inc | Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Neoplasms; Solid tumours; Stomach Neoplasms | Details |
| LNF-1802 | LNF1802; LNF-1802 | Phase 1 Clinical | Shandong New Time Pharmaceutical Co Ltd | | Details |
| ZGGS-15 | ZGGS15; ZGGS-15 | Phase 1 Clinical | Suzhou Zelgen Biopharmaceuticals Co Ltd | | Details |
| AUR-106 | AUR-106 | Phase 1 Clinical | Aurigene Discovery Technologies Ltd | Carcinoma, Non-Small-Cell Lung; Carcinoma, Transitional Cell; Colonic Neoplasms; Esophageal Neoplasms; Kidney Neoplasms; Neoplasms; Stomach Neoplasms | Details |
| BC008-1A | BC008-1A | Phase 1 Clinical | Sichuan Luzhou Buchang Biopharmaceutical Co Ltd | Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Glioblastoma; Glioma; Solid tumours | Details |
| SHR-2002 | SHR-2002 | Phase 1 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd, Suzhou Suncadia Biopharmaceuticals Co Ltd | | Details |
| PM-1021 | PM1021 | Phase 1 Clinical | | | Details |
| HH-101 | HH-101 | Phase 1 Clinical | Huahui Health Ltd | | Details |
| HB0030 | HB-0030 | Phase 1 Clinical | HuaBo Biopharm Co Ltd, Shanghai Huaota Biopharmaceutical Co Ltd | | Details |
| BAT-6005 | BAT-6005 | Phase 1 Clinical | Bio-Thera Solutions Ltd | | Details |
| IBI-321 | IBI-321 | Phase 1 Clinical | | | Details |
| Ralzapastotug | AB-308 | Phase 1 Clinical | Arcus Biosciences Inc | Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Gastroesophageal Junction Neoplasms; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Melanoma; Multiple Myeloma; Solid tumours; Stomach Neoplasms; Uterine Cervical Neoplasms | Details |
